Free Trial

Novo Nordisk A/S (NVO) Dividend Yield, Date & History

Novo Nordisk A/S logo
$69.08 -0.15 (-0.22%)
Closing price 05/5/2025 03:59 PM Eastern
Extended Trading
$68.21 -0.87 (-1.25%)
As of 07:40 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Novo Nordisk A/S Dividend Summary

Dividend Yield
2.36%
Annual Dividend
$1.63
Recent
Dividend Payment
Apr. 8
Annualized 3-Year
Dividend Growth
25.26%
Dividend Payout Ratio
49.54%

Novo Nordisk A/S (NVO) pays an annual dividend of $1.63 per share, with a dividend yield of 2.36%. The most recent annually payment of $0.7874 per share was paid on Tuesday, April 8, to investors who owned the stock before the ex-dividend date of Monday, March 31. The company currently pays out 49.54% of its earnings and 50.90% of its cash flow as dividends.

Get Dividend Stock Ideas Daily

Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news.

Sign Up
Skip Charts & View Dividend History

NVO Dividend Payments by Quarter

The chart below displays up to four years of Novo Nordisk A/S's dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.

NVO Dividend Yield Over Time

The chart below tracks Novo Nordisk A/S's dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.

Novo Nordisk A/S vs. The Competition

Compare Novo Nordisk A/S's annual dividend, yield, and 3-year growth rate with averages for Medical and NYSE companies to evaluate its performance against the market.

TypeNovo Nordisk A/SMedical CompaniesNYSE Companies
Annual Dividend$1.63$0.05$1.43
Dividend Yield2.36%5.37%3.96%
Annualized 3-Year Dividend Growth25.26%5.60%11.35%

Novo Nordisk A/S Dividend Payout Ratio

Dividend payout ratios express the dividend as a percentage of another metric, such as earnings or cash flow, and can be used to assess dividend sustainability.

TypePayout Ratio
Based on Trailing 12 Months of Earnings49.54%
Based on This Year's Estimate42.45%
Based on Next Year's Estimate34.98%
Based on Cashflow50.90%

Novo Nordisk A/S Dividend History by Quarter

AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date
2/5/2025semi-annual$0.7874+$0.2748
53.60%
1.2%3/31/20253/31/20254/8/2025
8/6/2024semi-annual$0.5126-$0.1514
22.80%
0.7%8/16/20248/16/20248/26/2024
1/31/2024Semi-Annual$0.6640+$0.4431
200.60%
0.9%3/22/20243/25/20244/2/2024
8/10/2023semi-annual$0.2209-$0.0763
25.67%
0.8%8/18/20238/21/20238/29/2023

This table shows Novo Nordisk A/S's annuallydividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time.

Novo Nordisk A/S Dividend - Frequently Asked Questions

The current dividend yield for Novo Nordisk A/S is 2.36%. Learn more on NVO's dividend yield history.

The annual dividend for NVO shares is $1.63. Learn more on NVO's annual dividend history.

Novo Nordisk A/S pays annually dividends to shareholders.

Novo Nordisk A/S's most recent annually dividend payment of $0.7874 per share was made to shareholders on Tuesday, April 8, 2025.

Novo Nordisk A/S's most recent ex-dividend date was Monday, March 31, 2025.

Over the past three years, the company's dividend has grown by an average of 25.26% per year.

The most recent change in the company's dividend was an increase of $0.2748 on Wednesday, February 5, 2025.

The dividend payout ratio for NVO is:
  • 49.54% based on the trailing year of earnings
  • 42.45% based on this year's estimates
  • 34.98% based on next year's estimates
  • 50.90% based on cash flow

Novo Nordisk A/S's dividend yield of 2.50% is lower than the average Medical company that issues a dividend. Novo Nordisk A/S's dividend payout ratio of 49.54% is at a healthy, sustainable level, below 75% of its earnings.

Looking at the stock as a whole, market analysts rate Novo Nordisk A/S stock as a Hold, forecasting limited upside or downside, with the stock seen as fairly valued at this time.


This page (NYSE:NVO) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners